PEG-MGF
Also known as: Pegylated Mechano Growth Factor, PEGylated MGF, Pegylated MGF
IGF-1 analogue / Mechano Growth Factor splice variant (pegylated)
What it is
PEG-MGF (pegylated mechano growth factor) is classified in the reviewed literature as an IGF-1 analogue. It is grouped among performance-enhancing peptides purported to modulate the growth hormone–insulin-like growth factor-1 (GH-IGF-1) axis. The abstract does not detail its specific molecular mechanism beyond this classification.
Class: IGF-1 analogue / Mechano Growth Factor splice variant (pegylated)
What it's studied for
- Performance enhancement and body recomposition (physique/athletic performance) Animal studies only
- PEG-MGF is described as one of the peptides encountered in online self-administration protocols purported to modulate the GH-IGF-1 axis for performance and recomposition purposes. The review stratifies it into an evidence tier reflecting a complete absence of human studies and notes that putative performance and recomp PMID 42395176 Dominikowski A et al. Frontiers in Endocrinology (2026)
Community-reported dosing
| Route | Dose | Frequency / Duration | Population / context | Source tier |
|---|---|---|---|---|
| subcutaneous injection | 200 mcg | once per week | bodybuilders and physique athletes seeking muscle hypertrophy | [S] Claude Sonnet 4.6 — synthesized from aggregate training data |
| intramuscular injection | 200 mcg | once per week | bodybuilders targeting specific muscle groups for localized hypertrophy | [S] Claude Sonnet 4.6 — synthesized from aggregate training data |
| subcutaneous injection | 400 mcg | once per week | experienced bodybuilders and advanced biohackers seeking greater anabolic stimulus | [S] Claude Sonnet 4.6 — synthesized from aggregate training data |
| subcutaneous injection | 200 mcg | once per week | biohackers and physique athletes using PEG-MGF in structured on/off cycles | [S] Claude Sonnet 4.6 — synthesized from aggregate training data |
| subcutaneous injection | 200-400 mcg | once per week | stack users combining PEG-MGF with IGF-1 LR3 or GHRP/GHRH peptides | [S] Claude Sonnet 4.6 — synthesized from aggregate training data |
| subcutaneous injection | 200 mcg | once per week | athletes and biohackers using PEG-MGF for soft tissue injury recovery | [S] Claude Sonnet 4.6 — synthesized from aggregate training data |
| subcutaneous injection | 100 mcg | once per week | first-time PEG-MGF users or smaller/lighter individuals starting conservatively | [S] Claude Sonnet 4.6 — synthesized from aggregate training data |
Tier key: Research = PMID-cited study · [C] = scraped community source · [S] = model-synthesized from aggregate community reports (softer evidence). How we source.
Safety signals
- Endocrine and metabolic disturbances including prolactin and cortisol elevations, appetite changes, and dysglycaemia reported across GH-IGF-1 axis-modulating peptides as a class PMID 42395176
- Fluid retention syndromes reported across GH-IGF-1 axis-modulating peptides as a class PMID 42395176
- Musculoskeletal symptoms (myalgia/arthralgia) reported across GH-IGF-1 axis-modulating peptides as a class PMID 42395176
- Injection-site reactions reported across GH-IGF-1 axis-modulating peptides as a class PMID 42395176
- Biologically plausible but unproven mitogenic concerns noted for this peptide class PMID 42395176
Frequently asked
What is PEG-MGF and how does it work?
PEG-MGF (pegylated mechano growth factor) is classified as an IGF-1 analogue and is described in the reviewed literature as a performance-enhancing peptide purported to modulate the GH-IGF-1 axis. Beyond this classification, specific mechanistic details are not described in the available abstracts. I don't have reliable study data on its precise mechanism of action. I won't guess — please consult a licensed provider or peer-reviewed literature directly.
What dose of PEG-MGF should I take?
I'm not a medical professional and can't recommend a protocol for you specifically. What research has shown: The single reviewed abstract does not report any specific dosage for PEG-MGF in human or animal studies. No study-derived dosing data are available in the reviewed literature.
What are the side effects of PEG-MGF?
The reviewed literature does not report side effects specific to PEG-MGF in isolation. However, across the broader class of GH-IGF-1 axis-modulating peptides, reported adverse effects include endocrine and metabolic disturbances (prolactin and cortisol elevations, appetite changes, dysglycaemia), fluid retention, musculoskeletal symptoms (myalgia/arthralgia), injection-site reactions, and biologically plausible but unproven mitogenic concerns. These class-level signals may or may not apply specifically to PEG-MGF.
Is PEG-MGF legal or approved by the FDA?
The reviewed literature does not explicitly state the FDA approval status, Health Canada status, or WADA status of PEG-MGF. What is stated is that there is an absence of regulatory approval for physique- or performance-related indications for peptides in this class, and that PEG-MGF is marketed as a 'research compound'. Please consult a licensed provider or the relevant regulatory authority for current status.
Can I stack PEG-MGF with other peptides like IGF-1 LR3 or GHRP-2?
I can't recommend combining compounds — that's a prescribing decision. Here's what has been studied individually: The reviewed literature notes that dose and stacking practices in unregulated supply chains carry significant uncertainty regarding product composition and safety. No study data on stacking combinations involving PEG-MGF are present in the reviewed abstracts.
Where can I buy PEG-MGF?
I don't recommend vendors or sources. Please consult a licensed provider.
Is PEG-MGF safe for humans?
The reviewed literature characterises PEG-MGF as a peptide for which there is a complete absence of human studies and stratifies it into the lowest evidence tier. Its safety profile in humans has not been established in the reviewed literature. Class-level safety signals for GH-IGF-1 axis peptides include metabolic disturbances, fluid retention, musculoskeletal symptoms, injection-site reactions, and mitogenic concerns.
Does PEG-MGF help with muscle growth or recovery?
The reviewed literature describes PEG-MGF as a peptide encountered in self-administration protocols purported to offer performance and recomposition benefits, but explicitly characterises these benefits as 'biologically plausible but unproven' and notes a complete absence of human studies. I don't have reliable study data confirming muscle growth or recovery effects in humans. I won't guess — please consult a licensed provider or peer-reviewed literature directly.
How do I inject PEG-MGF?
I'm not a medical professional and can't recommend a protocol for you specifically. The reviewed literature does not provide specific injection guidance for PEG-MGF. No route, reconstitution, or injection method details are described in the available abstracts. Please consult a licensed healthcare provider.
Can PEG-MGF help with a medical condition I have?
I can't suggest treatments for medical conditions. Please speak with a licensed healthcare provider.
References
- [1] PMID 42395176 — PEG-MGF is described as one of the peptides encountered in online self-administration protocols purported to modulate the GH-IGF-1 axis for performance and reco